DELMAR PAUL has a total of 14 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are JURILAB LTD OY, INTERLEUKIN GENETICS INC and INTEGRAGEN SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Delmar Paul | 14 |
#2 | Mcloughlin Patricia | 12 |
#3 | Lutz Verena | 11 |
#4 | Klughammer Barbara | 11 |
#5 | Delord Jean-Pierre | 2 |
#6 | Rochaix Philippe | 2 |
#7 | Thomas Fabienne | 2 |
#8 | Lutz Verna | 1 |
#9 | Kiughammer Barbara | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010015538A2 | Predictive marker for egfr inhibitor treatment | |
WO2010015535A1 | Predictive marker for egfr inhibitor treatment | |
US2011212979A1 | Predictive marker for egfr inhibitor treatment | |
US2011184004A1 | Predictive marker for egfr inhibitor treatment | |
US2011195982A1 | Predictive marker for egfr inhibitor treatment |